Immunohistochemical staining showed that HCC patients with low TXNDC12 expression displayed lower nuclear β-catenin expression levels than HCC patients with high TXNDC12 expression (Fig. 4a, Supplementary Fig. 3d). This evidence concerns the gene TXNDC12 and hepatocellular carcinoma.